Controlled trial of dexamethasone in neonatal chronic lung disease: An 8-year follow-up of cardiopulmonary function and growth

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 8, 2003, Pages 896-904

  Mieskonen, Suvi ^a   Eronen, M ^b   Malmberg, L P ^b   Turpeinen, M ^b   Kari, M A ^c   Hallman, M ^d  

^a JORVI HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Cardiomyopathy; Neurosensory development; Pulmonary hypertension; Respiratory function tests; Very low birthweight

Indexed keywords

DEXAMETHASONE;

ARTICLE; BRONCHUS OBSTRUCTION; CARDIOMYOPATHY; CARDIOVASCULAR FUNCTION; CHILD DEVELOPMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; LOW BIRTH WEIGHT; LUNG DISEASE; LUNG FUNCTION; MALE; NEUROLOGIC EXAMINATION; OSCILLOMETRY; PERCEPTION DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SKIN TEST; SPIROMETRY;

ANTI-INFLAMMATORY AGENTS; CHILD; CHRONIC DISEASE; DEXAMETHASONE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LUNG DISEASES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 0041874821     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310003451     Document Type: Article

References (31)

1. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 1992; 90: 663-8
2. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-32
3. Yoder MC Jr, Chua R, Tepper R. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1991; 143: 1044-8
4. Pelkonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997; 156: 1178-84
5. Malmberg LP, Mieskonen S, Pelkonen A, Karl A, Sovijärvi ARA, Turpeinen M. Lung function measured by the oscillometric method in prematurely born children with chronic lung disease. Eur Respir J 2000; 16: 598-603
6. Mieskonen ST, Malmberg LP, Kari MA, Pelkonen AS, Turpeinen MT, Hallman NMK, et al. Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. Pediatr Pulmonol 2002; 33: 347-55
7. Bush A, Busst CM, Knight WB, Hislop AA, Haworth SG, Shinebourne EA. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990; 65: 739-45
8. Farstad T, Brockmeier F, Bratlid D. Cardiopulmonary function in premature infants with bronchopulmonary dysplasia - a 2-year follow-up. Eur J Pediatr 1995; 154: 853-8
9. Collaborative dexamethasone trial group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 1991; 88: 421-7
10. Halliday HL, Ehrenkranz RA. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. [Review]. Cochrane Database of Systemic Reviews [Computer File]. 2000; 2: CD001146
11. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998; 101: e7
12. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weawe RG, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999; 104: 15-21
13. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000; 83: F177-81
14. Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. [Review]. Cochrane Database of Systemic Reviews [Computer File] 2000; 2: CD001144
15. Halliday HL, Ehrenkranz RA. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants [Review]. Cochrane Database of Systemic Reviews [Computer File] 2000; 2: CD001145
16. Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 566-9
17. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1 500 g. J Pediatr 1978; 92: 529-34
18. Anonymous. An international classification of retinopathy of prematurity. Pediatrics 1984; 74: 127-33
19. Jones R, Wincott E, Elbourne D, Grant A. A controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 1995; 96: 897-906
20. Sorva R, Lankinen S, Tolppanen E-M, Perheentupa J. Variation of growth in height and weight of children. Acta Paediatr Scand 1990; 79: 498-506
21. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-35
22. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: WB Saunders; 1971: 42-212
23. Vogel J, Smidt U. Impulse oscillometry. Frankfurt am Main: Pmi Verlagsgruppe GmbH; 1994
24. Duiverman E, Clément J, van de Woestinje K, Neijens H, van den Bergh A, Kerrebijn K. Forced oscillation technique. Reference values for resistance and reactance over a frequency spectrum of 2-26 Hz in healthy children aged 2.3-12.5 years. Bull Eur Physiopathol Respir 1985; 21: 171-8
25. Cotes J, Dabbs J, Hall A, Heywood C, Laurence K. Sitting height, fat free mass and body fat as reference variables for lung function in healthy British children; comparison with stature. Ann Hum Biol 1979; 6: 307-14
26. Subhedar N, Shaw NJ. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child 2000; 83: 243-7
27. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989; 320: 1505-10
28. Chan KN, Elliman A, Bryan E, Silverman M. Respiratory symptoms in children of low birth weight. Arch Dis Child 1989; 64: 1294-304
29. Bensky AS, Kothadia JM, Covitz W. Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics 1996; 97: 818-21
30. Riede FT, Schulze E, Vogt L, Scramm D. Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia. Pediatr Cardiol 2001; 22: 363-4
31. Motz R, Grassl G, Trawoger R. Dependence on a respiratory ventilator due to an atrial septal defect. Cardiol in the Young 2000; 10: 150-2